1
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:February 10, 2021Active, not recruiting
Abiraterone: 395 Clinical Trials, Page 1 of 40
Hide Studies Not Open or Pending
2
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:December 6, 2021Active, not recruiting
3
Optimizing Abiraterone Therapy
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:September 13, 2019Completed
4
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:June 22, 2022Active, not recruiting
5
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
Condition(s):Salivary Glands TumorsLast Updated:March 3, 2021Completed
6
Abiraterone-Rechallenge Study for CRPC Patients
Condition(s):Prostate CancerLast Updated:March 24, 2017Terminated
7
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Condition(s):Prostate Cancer Metastatic; Prostate CancerLast Updated:July 5, 2022Recruiting
8
Abiraterone Acetate Trial in African American Prostate Cancer Patients
Condition(s):Prostate CancerLast Updated:May 12, 2017Terminated
9
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
Condition(s):Abiraterone Acetate; Gene Polymorphism; Pharmacokinetic; Metabolic Analysis; Plasma ConcentrationLast Updated:January 3, 2022Active, not recruiting
10
A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone
Condition(s):PharmacokineticsLast Updated:March 4, 2020Completed